Active — Not RecruitingNot Applicable

Health in Work - a Measure for Increased Coping and Work Inclusion

Norway1,383 participantsStarted 2019-06-14

Plain-language summary

Health in work - a measure for increased coping and work participation -An effect analysis of a health- and work environment intervention at the workplace. Part 1:quantitative data collection The main objective of this study is to investigate the effect of the workplace intervention in the new Norwegian national programme Health in work (HelseIArbeid) through a pragmatic cluster-randomized study. The main hypothesis is that this interdisciplinary health and welfare intervention at the workplace reduces sick leave and improves mastering of common health problems more efficiently than a conventional welfare intervention. More specifically, it is hypothesized that the Health in work intervention has a better cost-effectiveness in terms of sick leave, use of health services and coping with common health problems indicated by an increased health-related quality of life.

Who can participate

Age range

18 Years – 70 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria for workplaces/workplace units: * minimum 8 employees * accessible data on sickness absence (both self- and physician-certified) in the workplace/workplace unit for the past two years prior to inclusion Inclusion Criteria for the individual employees: * all staff employed \> 20% in the participating workplaces/workplace units * Norwegian-speaking Exclusion Criteria for workplaces/workplace units: \- ongoing profound reorganisation at the workplace/workplace unit (\>20% change of employees within workplace unit) Exclusion Criteria for the individual employees: \- none

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change in overall sickness absence rates (self- and physician-certified) at the workplace (unit level)

Timeframe: Time period 24 months prior to randomization compared to the time period 12-24 months after randomization

Change in healthcare utilization

Timeframe: Time period 24 months prior to randomization compared to the time period 12-24 months after randomization

Change in health-related quality of life (HRQoL) by EQ-5D-5L utility value, including EQ-VAS score

Timeframe: Enrollment (Q1) to 12 months (Q2) and 24 months (Q3) after randomization

Health-economic analyses

Timeframe: Time period 24 months prior to randomization through 24 months after randomization

Trial details

NCT IDNCT04000035

SponsorUniversity Hospital of North Norway

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-07-01

View on ClinicalTrials.gov More Musculoskeletal Pain trials

Plain-language summary

Who can participate

Age range

18 Years – 70 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Change in overall sickness absence rates (self- and physician-certified) at the workplace (unit level)

Timeframe: Time period 24 months prior to randomization compared to the time period 12-24 months after randomization

Change in healthcare utilization

Timeframe: Time period 24 months prior to randomization compared to the time period 12-24 months after randomization

Change in health-related quality of life (HRQoL) by EQ-5D-5L utility value, including EQ-VAS score

Timeframe: Enrollment (Q1) to 12 months (Q2) and 24 months (Q3) after randomization

Health-economic analyses

Timeframe: Time period 24 months prior to randomization through 24 months after randomization